High incidence of sleep apnea syndrome in a male diabetic population

doi:10.1016/0168-8227(91)90032-9

Diabetes Research and Clinical Practice

Volume 13, Issues 1–2, 1991, Pages 45-51

https://doi.org/10.1016/0168-8227(91)90032-9 Get rights and content

Abstract

In order to study the possible relationship between sleep apnea syndrome (SAS) and diabetes mellitus, we first examined the prevalence of SAS among 12787 general patients (6554 males and 6233 females) who visited Katsumata Hospital at Nagoya, Japan. Among them, thirty-five males and five females were diagnosed as having SAS. The male patients were statistically analysed by the corrected Mantel-Haenszel χ-square test taking the body type into account, and it was found that the prevalence of SAS was significantly high both in a diabetic population and in a hypertensive one. Among 40 SAS patients of both sexes, 34 were given a glucose tolerance test (GTT) with oral administration of 75 g glucose. Thirteen showed a diabetic pattern, 12 a borderline pattern and only 9 had a normal pattern. All 13 diabetic patients had non-insulin-dependent type diabetes (NIDDM). The present results showed that SAS has a close relationship not only to hypertension but also to NIDDM.

References (13)

A. Kales et al.
Sleep apnea in a hypertensive population
Lancet November
(1984)
K. Katsumata et al.
Incidence of sleep apnea syndromes in general patients at a hospital for internal medicine
Nagoya J. Med. Sci.
(1986)
S. Mondini et al.
Abnormal breathing patterns during sleep in diabetes
Ann. Neurol.
(1985)
J.R. Catterall et al.
Breathing, sleep and diabetic autonomic neuropathy
Diabetes
(1984)
M.J. Tobin et al.
Breathing abnormalities during sleep
Arch. Intern. Med.
(1983)
A. Rechtschaffen et al.
A manual of standardized terminology and techniques on scoring system for sleep stage of human subjects
(1968)

There are more references available in the full text version of this article.

Cited by (78)

How can I manage anaesthesia in obese patients?
2020, Anaesthesia Critical Care and Pain Medicine
The obese patient is at risk of perioperative complications including difficult airway access (intubation, difficult or impossible ventilation), and postextubation acute respiratory failure due to the formation of atelectases or to airway obstruction. The association of obstructive sleep apnoea syndrome (OSA) with obesity is very common, and induces a high risk of per and postoperative complications. Preoperative OSA screening is crucial in the obese patient, as well as its specific management: use of continuous positive pre-, per- and postoperative pressure. For any obese patient, the implementation of difficult intubation protocols and the use of protective ventilation (low tidal volume 6–8 mL/kg of ideal body weight, moderate positive end-expiratory pressure of 10 cmH20, recruitment manoeuvres in absence of contra-indications), with morphine sparing and semi-seated positioning as much as possible are recommended, associated with a close postoperative monitoring. The dosage of anaesthetic drugs is usually based on the ideal body weight or the adjusted body weight and then titrated, except for succinylcholine that is dosed according to the total body weight. Monitoring of neuromuscular blockers should be used where appropriate, as well as monitoring of the depth of anaesthesia, especially when total intravenous anaesthesia is used in association with neuromuscular blockers. The occurrence of intraoperative awareness is indeed more frequent in the obese patient than in the non-obese patient. Appropriate prophylaxis against venous thromboembolism and early mobilisation are recommended, if possible included in an early rehabilitation protocol, to further reduce postoperative complications.
The association between sleep and diabetes outcomes – A systematic review
2020, Diabetes Research and Clinical Practice
Citation Excerpt :
Forty-one articles (n = 41) presented results of the prevalence of different sleep disorders in patients with diabetes (Fig. 2). The majority of studies measured the prevalence of sleep apnea disorders in diabetes (n = 25) [16–40], followed by restless leg syndrome (n = 11) [10,41–50], and periodic limb movement (n = 2) [51,52]. Three studies (n = 3) [52–54] did not specify the type of sleep disorder.
This study aimed to systematically review the prevalence of diagnosed sleep disorders in people with diabetes and to determine the association between sleep disorders and blood glucose levels and diabetes outcomes.
We conducted a literature search in the following databases: MEDLINE (Pubmed), EMBASE, CINAHL, PsychInfo and Web of Science Citation Index. Meta-analysis (random-effects models) was conducted to estimate the prevalence of sleep disorders in people with diabetes.
Forty-one articles measured the prevalence of sleep disorders in adults with diabetes. The estimated pooled prevalence of sleep disorders in diabetes was estimated to be 52% (95% CI 42–63%). The highest pooled prevalence was observed for unspecified sleep apnea (69%; 95% CI: 59–78%), followed by obstructive sleep apnea (60%; 95% CI 39–80%), and restless leg syndrome (27%; 95% CI 20–34%). Eleven studies examined the association between sleep disorders and diabetes control and complications. The presence of comorbid sleep disorders was associated with increased diabetes outcomes.
Diagnosed sleep disorders are highly prevalent in people with diabetes. Sleep disorders are associated with diabetes outcomes, though there was considerable heterogeneity across studies.
Preoperative risk and perioperative management of obese patients
2019, Revue des Maladies Respiratoires
Le patient obèse est à risque de complications péri-opératoires qui regroupent essentiellement l’accès difficile aux voies aériennes (intubation, ventilation difficile voire impossible), et les détresses respiratoires postextubation secondaires à la formation d’atélectasies ou à l’obstruction des voies aériennes, parfois associées à l’utilisation de dérivés morphiniques. L’association d’un syndrome d’apnées obstructives du sommeil (SAOS) à une obésité est très fréquente et participe au risque élevé de complications per- et post-opératoires. Le dépistage préopératoire du SAOS est crucial chez le patient obèse, ainsi que sa prise en charge spécifique le cas échant, basée sur l’utilisation d’une pression positive continue pré, per et post-opératoire. En péri-opératoire, la mise en place de protocoles de ventilation au masque et/ou d’intubation difficile et le recours à la ventilation protectrice, avec une épargne morphinique et un positionnement semi-assis tout au long de la prise en charge, est conseillée, associée à un monitorage rapproché en post-opératoire. Le dosage des médicaments anesthésiques est généralement basé sur le poids idéal théorique puis ensuite titré plutôt que dosé par rapport au poids total. Un monitoring du bloc neuromusculaire doit être utilisé lorsque le patient est curarisé, ainsi qu’un monitoring de la profondeur d’anesthésie. La survenue de mémorisation péri-opératoire est en effet plus fréquente chez le patient obèse que chez le patient non-obèse. En post-opératoire, une prophylaxie appropriée contre la maladie veineuse thromboembolique et une mobilisation précoce sont recommandées, la maladie thromboembolique étant d’incidence augmentée chez le patient obèse. L’usage de ventilation non invasive (VNI) post-opératoire afin de prévenir la survenue d’insuffisance respiratoire aiguë (VNI préventive) et ensuite de la traiter (VNI curative) est particulièrement efficace chez le patient obèse. En cas d’admission en réanimation, une prise en charge individualisée de la stratégie ventilatoire basée sur la physiopathologie et le monitorage devra être effectuée.
The obese patient is at an increased risk of perioperative complications. Most importantly, these include difficult access to the airways (intubation, difficult or impossible ventilation), and post-extubation respiratory distress secondary to the development of atelectasis or obstruction of the airways, sometimes associated with the use of morphine derivatives. The association of obstructive sleep apnea syndrome (OSA) with obesity is very common, and induces a high risk of peri- and postoperative complications. Preoperative OSA screening is crucial in the obese patient, as well as its specific management: use of continuous positive pre, per and postoperative pressure. For any obese patient, the implementation of protocols for mask ventilation and/or difficult intubation and the use of protective ventilation, morphine-sparing strategies and a semi-seated positioning throughout the care, is recommended, combined with close monitoring postoperatively. The dosage of anesthetic drugs should be based on the theoretical ideal weight and then titrated, rather than dosed to the total weight. Monitoring of neuromuscular blocking should be used where appropriate, as well as monitoring of the depth of anesthesia. The occurrence of intraoperative recall is indeed more frequent in the obese patient than in the non-obese patient. Appropriate prophylaxis against venous thromboembolic disease and early mobilization are recommended, as thromboembolic disease is increased in the obese patient. The use of non-invasive ventilation to prevent the occurrence of acute post-operative respiratory failure and for its treatment is particularly effective in obese patients. In case of admission to ICU, an individualized ventilatory management based on pathophysiology and careful monitoring should be initiated.
Short-term metabolic control and sleep in children and adolescents with type 1 diabetes mellitus
2018, Journal of Diabetes and its Complications
The aim of this study was to examine sleep in T1D children and in healthy controls by polysomnographic (PSG) examination and to determine the influence of short-term metabolic compensation on sleep quality and sleep disordered breathing (SDB).
The prospective cross-sectional study included 44 T1D subjects and 60 healthy controls, aged 10–19 years. Subjects underwent anthropometric measurements, laboratory testing and standard overnight in-laboratory video polysomnography with continuous glucose monitoring (CGM).
No significant differences were found in total sleep time, sleep efficiency, percentage of sleep stages and respiratory parameters between T1D and healthy group. T1D children with more optimal short-term metabolic control (AvgSG < 10 mmol/l, n = 18) had a significantly lower apnea-hypopnea index (AHI) (0.3(0–0.5) vs. 0.6 (0.2–0.9) events/h, p < 0.05)and respiratory arousal index (0(0–0,1) vs. 0.2(0–0.3)), p < 0.01) compared to children with suboptimal short-term control(n = 26), no significant differences were found in parameters of sleep architecture. Obstructive sleep apnea (OSA) was diagnosed in only one T1D patient, nine T1D children had mild central apnea.
There may be an association between short-term metabolic compensation and SDB in T1D children without chronic complications, obesity or overweight and hypoglycemia. Further research is needed to confirm this result.
Epidemiology of sleep-related complaints associated with sleep-disordered breathing in Bangkok, Thailand
2010, Sleep Medicine
Citation Excerpt :
The next logical step would be to investigate polysomnographic data and correlate it to these subjective findings to investigate whether the symptoms that prompt the Western population to suspect and formally evaluate potential sleep-disordered breathing are similarly applicable to the Eastern population. The association between cardiovascular and endocrine diseases with snoring and EDS in our population is remarkably consistent with other epidemiologic studies from other populations [47–51]. Unlike Caucasian populations, we found a greater prevalence of cardiovascular disease in the general female population.
This study assesses the prevalence of and risk factors for sleep-related complaints in Bangkok, Thailand.
A representative sample of the Bangkok population was selected based on results of the 2000 Census. A total of 4680 participants underwent face-to-face interview with a 49-question sleep inventory.
Four percent of the total sampled (5.3% of men and 3.5% of women) complained of habitual snoring (>3 nights/week) and excessive daytime sleepiness (>3 days/week) for at least 3 months. These subjects were significantly (p < 0.0001) older (41.4 vs. 36.7 years), had greater BMI (26.0 vs. 22.8 kg/m²), neck size (34.7 vs. 32.5 cms), and waist circumference (88.0 vs. 78.7 cms). They reported significantly shorter nocturnal sleep time, greater frequency of sleep disturbances and awakenings, unrefreshing sleep, choking during sleep, night sweats, nocturia, and bruxism. There was also a greater prevalence of cardiovascular and endocrine diseases. Multivariate analysis showed that male gender; BMI; waist size; and reports of witnessed apneas, unrefreshing sleep and night sweats were significant predictors of snoring and daytime sleepiness.
This is the first epidemiologic study investigating sleep-related complaints and associated health morbidities in the Thai population.
Endocrine Physiology in Relation to Sleep and Sleep Disturbances
2010, Principles and Practice of Sleep Medicine: Fifth Edition

View all citing articles on Scopus

View full text

High incidence of sleep apnea syndrome in a male diabetic population

Abstract

Lancet November

Incidence of sleep apnea syndromes in general patients at a hospital for internal medicine

Nagoya J. Med. Sci.

Abnormal breathing patterns during sleep in diabetes

Ann. Neurol.

Breathing, sleep and diabetic autonomic neuropathy

Diabetes

Breathing abnormalities during sleep

Arch. Intern. Med.

A manual of standardized terminology and techniques on scoring system for sleep stage of human subjects